Literature DB >> 17216534

Novel 'phage display antibodies identify distinct heparan sulfate domains in developing mammalian lung.

S M Thompson1, M G Connell, D G Fernig, G B Ten Dam, T H van Kuppevelt, J E Turnbull, E C Jesudason, P D Losty.   

Abstract

Heparan sulfate proteoglycans (HSPGs) are essential to respiratory morphogenesis in species as diverse as Drosophila and mice; they play a role in the regulation of numerous HS-binding growth factors, e.g. fibroblast growth factors. Moreover, an HS analogue, heparin, modulates lung growth in vitro. However, it has been difficult to assess the roles of specific HS structures in lung development due to technical barriers to their spatial localisation. Lungs from Sprague-Dawley rats were harvested between E15.5 and E19.5 and immediately fixed in 4 % (w/v) paraformaldehyde (in 0.1 M phosphate-buffered saline (PBS), pH 7.4). Lungs were washed in PBS, cryoprotected with 20% (w/v) sucrose (in PBS), gelatin embedded [7.5% (w/v) gelatin, 15% (w/v) sucrose in PBS], before being covered in Cryo-M-Bed (Bright, Huntingdon, UK) and snap frozen at -40 degrees C. Cryosections were cut at 8 microm and stained with the HSPG core protein specific antibody 3G10 and a HS 'phage display antibody, EW4G2V. 3G10 and EW4G2V immunohistochemistry highlighted the presence of specific HS structures in lungs at all gestational ages examined. 3G10 strongly labelled airway basement membranes and the surrounding mesenchyme and showed weak staining of airway epithelial cells. EW4G2V, however, was far more selective, labelling the airway basement membranes only. Mesenchymal and epithelial cells did not appear to possess the HS epitope recognised by EW4G2V at these gestational ages. Novel 'phage display antibodies allow the spatial distribution of tissue HS to be analysed, and demonstrate in situ that distinct cellular compartments of a tissue possess different HS structures, possibly on the same proteoglycan core protein. These probes offer a new opportunity to determine the role of HS in the pathogenesis of congenital defects such as congenital diaphragmatic hernia (CDH), where lung development is aberrant, and the resulting pulmonary hypoplasia and hypertension are a primary cause of mortality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17216534     DOI: 10.1007/s00383-006-1864-8

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   2.003


  44 in total

1.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation.

Authors:  A C Rapraeger; A Krufka; B B Olwin
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

2.  3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3.

Authors:  Gerdy B Ten Dam; Sindhulakshmi Kurup; Els M A van de Westerlo; Elly M M Versteeg; Ulf Lindahl; Dorothe Spillmann; Toin H van Kuppevelt
Journal:  J Biol Chem       Date:  2005-12-22       Impact factor: 5.157

3.  branchless encodes a Drosophila FGF homolog that controls tracheal cell migration and the pattern of branching.

Authors:  D Sutherland; C Samakovlis; M A Krasnow
Journal:  Cell       Date:  1996-12-13       Impact factor: 41.582

4.  Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides.

Authors:  S E Guimond; J E Turnbull
Journal:  Curr Biol       Date:  1999-11-18       Impact factor: 10.834

5.  Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice.

Authors:  X Lin; G Wei; Z Shi; L Dryer; J D Esko; D E Wells; M M Matzuk
Journal:  Dev Biol       Date:  2000-08-15       Impact factor: 3.582

6.  Fibroblast growth factor-2 stimulation of p42/44MAPK phosphorylation and IkappaB degradation is regulated by heparan sulfate/heparin in rat mammary fibroblasts.

Authors:  M Delehedde; M Seve; N Sergeant; I Wartelle; M Lyon; P S Rudland; D G Fernig
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

7.  Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality.

Authors:  Jin-Ping Li; Feng Gong; Asa Hagner-McWhirter; Erik Forsberg; Magnus Abrink; Robert Kisilevsky; Xiao Zhang; Ulf Lindahl
Journal:  J Biol Chem       Date:  2003-06-04       Impact factor: 5.157

8.  In vivo localization of the insulin-like growth factors I and II (IGF I and IGF II) gene expression during human lung development.

Authors:  A V Lallemand; S M Ruocco; P M Joly; D A Gaillard
Journal:  Int J Dev Biol       Date:  1995-06       Impact factor: 2.203

9.  Expression of insulin-like growth factor receptors 1 and 2 in the developing lung and their relation to epithelial cell differentiation.

Authors:  B Maitre; A Clement; M C Williams; J S Brody
Journal:  Am J Respir Cell Mol Biol       Date:  1995-09       Impact factor: 6.914

10.  Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung.

Authors:  S Bellusci; J Grindley; H Emoto; N Itoh; B L Hogan
Journal:  Development       Date:  1997-12       Impact factor: 6.868

View more
  10 in total

Review 1.  Proteoglycomics: recent progress and future challenges.

Authors:  Mellisa Ly; Tatiana N Laremore; Robert J Linhardt
Journal:  OMICS       Date:  2010-08

Review 2.  Heparan sulfate-protein binding specificity.

Authors:  M A Nugent; J Zaia; J L Spencer
Journal:  Biochemistry (Mosc)       Date:  2013-07       Impact factor: 2.487

Review 3.  Growth factor-heparan sulfate "switches" regulating stages of branching morphogenesis.

Authors:  Sanjay K Nigam; Kevin T Bush
Journal:  Pediatr Nephrol       Date:  2014-02-02       Impact factor: 3.714

Review 4.  The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans.

Authors:  Kevin J McCarthy; Deborah J Wassenhove-McCarthy
Journal:  Microsc Microanal       Date:  2012-02       Impact factor: 4.127

5.  Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation?

Authors:  Sophie M Thompson; Marilyn G Connell; Toin H van Kuppevelt; Ruoyan Xu; Jeremy E Turnbull; Paul D Losty; David G Fernig; Edwin C Jesudason
Journal:  BMC Dev Biol       Date:  2011-06-14       Impact factor: 1.978

6.  Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities.

Authors:  Sophie M Thompson; David G Fernig; Edwin C Jesudason; Paul D Losty; Els M A van de Westerlo; Toin H van Kuppevelt; Jeremy E Turnbull
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

7.  Heparan sulfate separation, sequencing, and isomeric differentiation: ion mobility spectrometry reveals specific iduronic and glucuronic acid-containing hexasaccharides.

Authors:  Matthew R Schenauer; John K Meissen; Youjin Seo; James B Ames; Julie A Leary
Journal:  Anal Chem       Date:  2009-12-15       Impact factor: 6.986

8.  Acellular lung scaffolds direct differentiation of endoderm to functional airway epithelial cells: requirement of matrix-bound HS proteoglycans.

Authors:  Sharareh Shojaie; Leonardo Ermini; Cameron Ackerley; Jinxia Wang; Stephanie Chin; Behzad Yeganeh; Mélanie Bilodeau; Manpreet Sambi; Ian Rogers; Janet Rossant; Christine E Bear; Martin Post
Journal:  Stem Cell Reports       Date:  2015-02-05       Impact factor: 7.765

9.  Glycomics approaches for the bioassay and structural analysis of heparin/heparan sulphates.

Authors:  Tania M Puvirajesinghe; Jeremy E Turnbull
Journal:  Metabolites       Date:  2012-11-28

Review 10.  The Extracellular Matrix in Bronchopulmonary Dysplasia: Target and Source.

Authors:  Ivana Mižíková; Rory E Morty
Journal:  Front Med (Lausanne)       Date:  2015-12-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.